These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 3356752
21. Heterogeneity in p53 mutations in mouse mammary tumor subpopulations with different metastatic potential from the orthotopic site. Shekhar PV, Werdell J, Christman JK, Miller FR. Anticancer Res; 1995; 15(3):815-20. PubMed ID: 7645964 [Abstract] [Full Text] [Related]
22. Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Tsuruo T, Yamori T, Naganuma K, Tsukagoshi S, Sakurai Y. Cancer Res; 1983 Nov; 43(11):5437-42. PubMed ID: 6616476 [Abstract] [Full Text] [Related]
23. Epithelial characteristics of five subpopulations of a heterogeneous strain BALB/cfC3H mouse mammary tumor. Hager JC, Russo J, Ceriani RL, Peterson JA, Fligiel S, Jolly G, Heppner GH. Cancer Res; 1981 May; 41(5):1720-30. PubMed ID: 6260349 [Abstract] [Full Text] [Related]
24. Spontaneous and induced metastasis of naturally occurring tumors in mice: analysis of cell shedding into the blood. Price JE, Carr D, Tarin D. J Natl Cancer Inst; 1984 Dec; 73(6):1319-26. PubMed ID: 6096621 [Abstract] [Full Text] [Related]
26. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line. Yamashina K, Miller BE, Heppner GH. Cancer Res; 1986 May; 46(5):2396-401. PubMed ID: 3084067 [Abstract] [Full Text] [Related]
27. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma. Hoon DB, Ziola B, Ramshaw I. Cancer Res; 1984 Jun; 44(6):2406-9. PubMed ID: 6722781 [Abstract] [Full Text] [Related]
28. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Ford HL, Salim MM, Chakravarty R, Aluiddin V, Zain SB. Oncogene; 1995 Nov 16; 11(10):2067-75. PubMed ID: 7478526 [Abstract] [Full Text] [Related]
30. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies. Rapp L, Fuji H. Cancer Res; 1983 Jun 16; 43(6):2592-9. PubMed ID: 6342755 [Abstract] [Full Text] [Related]
32. Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells. Nakanishi H, Oguri K, Takenaga K, Hosoda S, Okayama M. Lab Invest; 1994 Mar 16; 70(3):324-32. PubMed ID: 7511714 [Abstract] [Full Text] [Related]
33. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oates AJ, Barraclough R, Rudland PS. Oncogene; 1996 Jul 04; 13(1):97-104. PubMed ID: 8700559 [Abstract] [Full Text] [Related]
34. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Pulaski BA, Ostrand-Rosenberg S. Cancer Res; 1998 Apr 01; 58(7):1486-93. PubMed ID: 9537252 [Abstract] [Full Text] [Related]
36. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Brantley-Sieders DM, Fang WB, Hwang Y, Hicks D, Chen J. Cancer Res; 2006 Nov 01; 66(21):10315-24. PubMed ID: 17079451 [Abstract] [Full Text] [Related]